NCT02658214 2020-08-20Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsAstraZenecaPhase 1 Completed32 enrolled
NCT00557206 2013-11-05Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck CancerMinneapolis Veterans Affairs Medical CenterPhase 2 Terminated35 enrolled